N-methyl-D-aspartate-enhanced analgesia

Current Pain and Headache Reports

Volumn 7, Issue 1, 2003, Pages 43-47

  Hewitt, David J ^a  

^a Ortho McNeil Pharmaceutical Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; AMANTADINE; ANALGESIC AGENT; DEXTROMETHORPHAN; DEXTROMETHORPHAN PLUS MORPHINE; KETAMINE; MEMANTINE; METHADONE; MORPHINE; MORPHINE SULFATE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OPIATE; OPIATE AGONIST; NARCOTIC ANALGESIC AGENT;

ANALGESIA; ANALGESIC ACTIVITY; ANTINOCICEPTION; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; CLINICAL TRIAL; COGNITIVE DEFECT; DRUG SYNTHESIS; DRUG TARGETING; DRUG TOLERANCE; HUMAN; HYPERALGESIA; MEMORY DISORDER; MODULATION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN; PERIPHERAL NERVOUS SYSTEM; POSTOPERATIVE PAIN; RESPIRATION DEPRESSION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; NOCICEPTIVE RECEPTOR; PAIN THRESHOLD; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANALGESICS; ANALGESICS, OPIOID; ANIMALS; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; HUMANS; NOCICEPTORS; PAIN; PAIN THRESHOLD; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0037315351     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-003-0009-1     Document Type: Review

References (30)

1. Foley KM: Changing concepts of tolerance to opioids. In Current and Emerging Issues in Cancer Pain: Research and Practice (The Bristol-Myers Squibb Symposium on Pain Research). Edited by Chapman CR, Foley KM. New York: Raven Press, 1993:331-350.
2. Mao J, Price DD, Mayer-DJ: Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 1995, 62:259-274.
3. Woolf CJ, Thompson SW: The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states. Pain 1991, 44:293-299.
4. Woolf CJ, Wall PD: Relative effectiveness of C primary afferent fibers of different origins in evoking a prolonged facilitation of the flexor reflex in the rat. J Neurosci 1986, 6:1433-1442.
5. Park KM, Max MB, Robinovitz E, et al.: Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects. Pain 1995, 63:163-172.
6. Warncke T, Stubhaug A, Jorum E: Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo. Pain, 1997, 72:99-106.
7. Vick PG, Lamer TJ: Treatment of post-stroke pain with oral ketamine. Pain 2001, 92:311-313.
8. Eide K, Stubhaug A, Oye I, Breivik H: Continuous subcutaneous administration of the N-methyl-D-aspartate receptor antagonist ketamine in the treatment of postherpetic neuralgia. Pain 1995, 61:221-8.
9. Nikolajsen L, Hansen CL, Nielsen J, et al.: The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input. Pain 1996, 67:69-77.
10. Nelson KA, Park KM, Robinovitz E, et al.: High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology. 1997, 48:1212-1218.
11. Nikolajsen L, Gottrup H, Kristensen A, Jensen T: Mamantine (a N-methyl-D-aspartate receptor antagonist) in the treatment of neuropathic pain after amputation or surgery: a randomized, double-blinded, cross-over study. Anesthesia Anal 2000, 91:960-966.
12. Mercadante S, Lodi F, Sapio M, et al.: Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain. J Pain Symptom Manage 1995, 10:564-568.
13. Mercadante S, Arcuri E, Tirelli W, et al.: Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study. J Pain Symtom Manage 2000, 20:246-252.
14. Pud D, Eisenberg E, Spitzer A, et al.: The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial. Pain 1998, 75:349-354.
15. Max MB, Byas-Smith MG, Gracely RH, et al.: Intravenous infusion of the NMDA antagonist, ketamine, in chronic post-traumatic pain and allodynia: a double-blind comparison with alfentanil and placebo. Clin Neuropharmacol 1995, 18:360-368.
16. Persson J, Axelsson G, Hallin RG, et al.: Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization. Pain 1995, 60:217-222.
17. Gorman A, Elliott KJ, Inturrisi CE: The d- and l- isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci Lett 1997, 223:5-8.
18. Manning BH, Mao J, Frenk H, et al.: Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance. Pain 1996, 67:79-88.
19. Mao J, Price DD, Caruso FS, et al.: Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats. Pain 1996, 57:361-368.
20. Shimoyama N, Shimoyama M, Inturrisi CE, Elliott K: Ketamine attenuates and reverses morphine tolerance in rodents. Anesthesiology 1996, 85:1357-1366.
21. Weinbroum AA, Ben-Abraham R: Dextromethorphan and dexmedetomidine: new agents for the control of perioperative pain. Eur J Surg 2001, 167:563-569.
22. Weinbroum AA, Lalayev G, Yashar T, et al.: Combined preincisional oral dextromethorphan and epidural lidocaine for postoperative pain reduction and morphine sparing: a randomized double-blind study on day surgery patients. Anaesthesia 2001, 56:616-622.
23. Ilkjaer S, Bach LF, Nielsen PA, et al.: Effect of preoperative oral dextromethorphan on immediate and late postoperative pain and hyperalgesia after total abdominal hysterectomy. Pain 2000, 86:19-24.
24. Grace RF, Power I, Umedaly H, et al.: Preoperative dextromethorphan reduces intraoperative, but not postoperative morphine requirements after laparotomy. Anesth Analg 1998, 87:1135-1138.
25. Kannan TR, Saxena A, Bhatnagear S, Barry A: Oral ketamine as an adjuvant to oral morphine in neuropathic pain in cancer patients. J Pain Symptom Manage 2002, 23:60-65.
26. Gottschalk A, Schroeder F, Ufer M, et al.: Amantadine, a N-methyl-D-aspartate receptor antagonist, does not enhance postoperative analgesia in women undergoing abdominal hysterectomy. Anesthes Analg 2001, 93:192-196.
27. Helmy S, Bali A: The effect of the preemptive use of the NMDA receptor antagonist dextromethorphan on postoperative analgesic requirements. Anesthes Analg 2001, 92:739-744.
28. Chia YY, Liu K, Chow LH, et al.: The preoperative administration of intravenous dextromethorphan reduces postoperative morphine consumption. Anesth Analg 1999, 89:748-752.
29. Weinbroum AA: Dextromethorphan reduces immediate and late postoperative analgesic requirements and improves patients' subjective scorings after epidural lidocaine and general anesthesia. Anesthes Analge 2002, 94:1547-1552.
30. Katz NP: MorphiDex (MS:DM) double-blind, multiple-dose studies in chronic pain patients. J Pain Symptom Manage 2000, 19:S37-S41.